Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome

Sex differences in T cell immune responses, gut permeability and outcome after ischemic stroke in aged mice

(2020) Hilda Ahnstedt et al.   BRAIN BEHAVIOR AND IMMUNITY

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

(2020) Qian-Ting Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway

(2020) Hui Zhong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma

(2020) Nandakumar Packiriswamy et al.   LEUKEMIA

Peptide vaccine with glucopyranosyl lipid A–stable oil-in-water emulsion for patients with resected melanoma

(2020) Eric P Grewal et al.   Immunotherapy

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine

(2020) María Pulido et al.   Cancers

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

(2020) Hans Raskov et al.   BRITISH JOURNAL OF CANCER

Mannosylated glycoliposomes for the delivery of a peptide kappa opioid receptor antagonist to the brain

(2020) Jordan D. Lewicky et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Therapeutic Vaccines and Cancer Immunotherapy

(2020) Darshak Bhatt et al.   Vaccines

Emerging immunotherapies for metastasis

(2020) Sarah C. Edwards et al.   BRITISH JOURNAL OF CANCER

First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1

(2019) Amit Mahipal et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments

(2019) Anusha Pusuluri et al.   JOURNAL OF CONTROLLED RELEASE

Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion

(2019) Crescenzo D’Alterio et al.   SEMINARS IN CANCER BIOLOGY

Are 90% of deaths from cancer caused by metastases?

(2019) Hanna Dillekås et al.   Cancer Medicine

Combination Immunotherapy with Cytotoxic T-Lymphocyte–Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis

(2019) Ting Sun et al.   MOLECULAR CANCER THERAPEUTICS

Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases

(2018) Chun Gwon Park et al.   Science Translational Medicine

Age-Related Decline in Primary CD8 + T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8 + T Cells

(2018) Kylie M. Quinn et al.   Cell Reports

Strengthening peptide-based drug activity with novel glyconanoparticle

(2018) Jordan D. Lewicky et al.   PLoS One

Cytokines in clinical cancer immunotherapy

(2018) Pedro Berraondo et al.   BRITISH JOURNAL OF CANCER

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

(2018) Jorge E. Cortes et al.   LEUKEMIA

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy

(2018) Sanja Nabergoj et al.   MEDICINAL RESEARCH REVIEWS

Biological sex affects vaccine efficacy and protection against influenza in mice

(2018) Ashley L. Fink et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy

(2017) Chuangnian Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Recent developments in immunotherapy of acute myeloid leukemia

(2017) Felix S. Lichtenegger et al.   Journal of Hematology & Oncology

Tumour-associated macrophages as treatment targets in oncology

(2017) Alberto Mantovani et al.   Nature Reviews Clinical Oncology

Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer

(2017) Juming Yan et al.   Cold Spring Harbor Perspectives in Biology

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

(2017) Patrick M. Dillon et al.   Journal for ImmunoTherapy of Cancer

Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation

(2017) Fawaz Awad et al.   PLoS One

A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells

(2016) Jelani C. Zarif et al.   BIOTECHNIQUES

Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells

(2016) E. Beyranvand Nejad et al.   CANCER RESEARCH

The urgent need to recover MHC class I in cancers for effective immunotherapy

(2016) Federico Garrido et al.   CURRENT OPINION IN IMMUNOLOGY

Expedient synthesis of functional single-component glycoliposomes using thiol–yne chemistry

(2016) D. Goyard et al.   Journal of Materials Chemistry B

Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis

(2016) Bodo E. Lippitz et al.   OncoImmunology

In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model

(2015) Joana M. Silva et al.   JOURNAL OF CONTROLLED RELEASE

Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid

(2015) Elisabeth Ersvaer et al.   BMC Pharmacology & Toxicology

Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity

(2014) Eleni Maria Varypataki et al.   AAPS Journal

An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment

(2014) J. D. Gibbins et al.   BLOOD

c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis

(2014) A. Nanbakhsh et al.   BLOOD

Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFN 

(2014) A. Textor et al.   CANCER RESEARCH

The two faces of IL-6 in the tumor microenvironment

(2014) Daniel T. Fisher et al.   SEMINARS IN IMMUNOLOGY

Chemoimmunotherapy: reengineering tumor immunity

(2013) Gang Chen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunization with Biodegradable Nanoparticles Efficiently Induces Cellular Immunity and Protects against Influenza Virus Infection

(2013) T. Knuschke et al.   JOURNAL OF IMMUNOLOGY

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer

(2013) Robert Wesolowski et al.   Journal for ImmunoTherapy of Cancer

Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy

(2012) Mariana S. Nars et al.   INTERNATIONAL JOURNAL OF CANCER

How much of Virus-Specific CD8 T Cell Reactivity is Detected with a Peptide Pool when Compared to Individual Peptides?

(2012) Wenji Zhang et al.   Viruses-Basel

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

(2011) Takami Sato et al.   IMMUNOLOGIC RESEARCH

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity

(2010) J. Vincent et al.   CANCER RESEARCH

Sequential Cytarabine and  -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

(2010) T. L. Rosenblat et al.   CLINICAL CANCER RESEARCH

Enhancement of the anti-tumor efficacy of a GM-CSF–secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside

(2008) J LIN   EXPERIMENTAL HEMATOLOGY